
According to a report from Seekingalpha, the share price of British American Tobacco (BAT) ended its six-day upward trend on January 9th, experiencing a 1.2% drop during afternoon trading and closing at a price of $30.20.
The company's stock price has risen by approximately 4.3% over the past six trading days. However, overall, the company's stock price has dropped by 24% in the past year, contrasting with the broader S&P 500 index which has seen a 22% increase. On January 8th, the company's shares closed at $30.57, marking a 0.9% increase. For British American Tobacco, the performance in December was mixed, with 11 trading days showing an increase and 9 trading days experiencing a decline.
Among the analysts on Wall Street, three have strongly recommended buying stocks of BAT, while one has given a buy recommendation. One analyst has suggested holding the stock, while no one has recommended selling or strongly selling it.
Earlier last month, the company made a $31.5 billion write-down on the value of its American cigarette brands, which sent shockwaves through the investor community. While some analysts view this as a buying opportunity, analysis reveals concerns among people regarding potential additional expenses that other tobacco companies might incur as a result of BAT's recent write-down.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com